Prospera Financial Services’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-50
Closed -$6K 2527
2022
Q1
$6K Sell
50
-14,416
-100% -$1.68M ﹤0.01% 2233
2021
Q4
$2.18M Buy
+14,466
New +$1.95M 0.09% 250
2020
Q4
Sell
-50
Closed -$6K 1492
2020
Q3
$6K Buy
+50
New +$5.25K ﹤0.01% 1255

Other funds holding TNDM

Prospera Financial Services's TNDM Position: Q2 2022 in Review

Prospera Financial Services sold out of Tandem Diabetes Care (TNDM) in Q2 2022, closing a stake of 50 shares — an estimated $6K sold.

Prospera Financial Services first reported a position in TNDM in Q3 2020 and held it in 3 quarters. The position peaked at $2.18M in Q4 2021. 330 funds tracked by Wall St. Rank hold TNDM as of Q2 2022.

  • Prospera Financial Services reported no remaining Tandem Diabetes Care position as of Q2 2022 after selling out during the quarter.
  • Prospera Financial Services sold 50 Tandem Diabetes Care shares in Q2 2022, an estimated $6K.
  • Prospera Financial Services first reported a position in Tandem Diabetes Care in Q3 2020 and held it in 3 quarters.
  • Prospera Financial Services's Tandem Diabetes Care position peaked at $2.18M in Q4 2021.
  • 330 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2022.

Based on Prospera Financial Services's 13F filing for Q2 2022, filed 8 Aug 2022.